Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-343 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-635 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4965 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-343 |
filingDate |
2012-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2014-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2014-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-101456754-B1 |
titleOfInvention |
Parmaceutical Composition for Preventing or Treating Cancer Containing ABT-737 and Cafestol |
abstract |
The present invention relates to a pharmaceutical composition for the prevention or treatment of cancer comprising ABT-737 and cafestol as an active ingredient. In the case of using ABT-737 and cafestol in combination, cancer cell-specific cell death And exhibits excellent anticancer activity in cancer cells overexpressing Mcl-1. Therefore, it can be usefully used for the prophylaxis or treatment of cancer, particularly, renal cancer. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20230051845-A |
priorityDate |
2012-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |